BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37996972)

  • 1. Identification of target cells of human papillomavirus 18 using squamocolumnar junction organoids.
    Toyohara Y; Taguchi A; Ishii Y; Yoshimoto D; Yamazaki M; Matsunaga H; Nakatani K; Hoshi D; Tsuchimochi S; Kusakabe M; Baba S; Kawata A; Ikemura M; Tanikawa M; Sone K; Uchino-Mori M; Ushiku T; Takeyama H; Oda K; Kawana K; Hippo Y; Osuga Y
    Cancer Sci; 2024 Jan; 115(1):125-138. PubMed ID: 37996972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of organoid culture from HPV18-positive small cell carcinoma of the uterine cervix for precision medicine.
    Kusakabe M; Taguchi A; Tanikawa M; Hoshi D; Tsuchimochi S; Qian X; Toyohara Y; Kawata A; Wagatsuma R; Yamaguchi K; Yamamoto Y; Ikemura M; Sone K; Mori-Uchino M; Matsunaga H; Tsuruga T; Nagamatsu T; Kukimoto I; Wada-Hiraike O; Kawazu M; Ushiku T; Takeyama H; Oda K; Kawana K; Hippo Y; Osuga Y
    Cancer Med; 2023 Apr; 12(7):8476-8489. PubMed ID: 36691316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology of human papillomavirus 18 infections in Japanese Women.
    Yamaguchi-Naka M; Onuki M; Tenjimbayashi Y; Hirose Y; Tasaka N; Satoh T; Morisada T; Iwata T; Sekizawa A; Matsumoto K; Kukimoto I
    Infect Genet Evol; 2020 Sep; 83():104345. PubMed ID: 32360473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
    Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus (HPV) 18 genetic variants and cervical cancer risk in Taizhou area, China.
    Xu HH; Zheng LZ; Lin AF; Dong SS; Chai ZY; Yan WH
    Gene; 2018 Mar; 647():192-197. PubMed ID: 29331480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic human papillomavirus-infected immature metaplastic cells and cervical neoplasia.
    van der Marel J; van Baars R; Alonso I; del Pino M; van de Sandt M; Lindeman J; ter Harmsel B; Boon M; Smedts F; Ordi J; Torné A; Jenkins D; Quint W
    Am J Surg Pathol; 2014 Apr; 38(4):470-9. PubMed ID: 24503756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentially expressed genes between high-risk human papillomavirus types in human cervical cancer cells.
    Vazquez-Ortiz G; García JA; Ciudad CJ; Noé V; Peñuelas S; López-Romero R; Mendoza-Lorenzo P; Piña-Sánchez P; Salcedo M
    Int J Gynecol Cancer; 2007; 17(2):484-91. PubMed ID: 17309674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenesis and management of human papillomavirus-associated cervical cancer.
    Kusakabe M; Taguchi A; Sone K; Mori M; Osuga Y
    Int J Clin Oncol; 2023 Aug; 28(8):965-974. PubMed ID: 37294390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1.
    Liu H; Xu J; Yang Y; Wang X; Wu E; Majerciak V; Zhang T; Steenbergen RDM; Wang HK; Banerjee NS; Li Y; Lu W; Meyers C; Zhu J; Xie X; Chow LT; Zheng ZM
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33436409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of Human Papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma.
    Quint KD; de Koning MN; Geraets DT; Quint WG; Pirog EC
    Gynecol Oncol; 2009 Sep; 114(3):390-4. PubMed ID: 19500822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis.
    de Wilde J; Kooter JM; Overmeer RM; Claassen-Kramer D; Meijer CJ; Snijders PJ; Steenbergen RD
    BMC Cancer; 2010 Jun; 10():271. PubMed ID: 20534141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
    Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
    Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.
    Theelen W; Litjens RJ; Vinokurova S; Haesevoets A; Reijans M; Simons G; Smedts F; Herrington CS; Ramaekers FC; von Knebel Doeberitz M; Speel EJ; Hopman AH
    Hum Pathol; 2013 Nov; 44(11):2410-8. PubMed ID: 23968641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cells with stem-like properties are associated with the development of HPV18-positive cervical cancer.
    Kusakabe M; Taguchi A; Tanikawa M; Wagatsuma R; Yamazaki M; Tsuchimochi S; Toyohara Y; Kawata A; Baba S; Ueno T; Sone K; Mori-Uchino M; Ikemura M; Matsunaga H; Nagamatsu T; Wada-Hiraike O; Kawazu M; Ushiku T; Takeyama H; Oda K; Kawana K; Mano H; Osuga Y
    Cancer Sci; 2023 Mar; 114(3):885-895. PubMed ID: 36404139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fifteen new nucleotide substitutions in variants of human papillomavirus 18 in Korea : Korean HPV18 variants and clinical manifestation.
    Kim N; Park JS; Kim JE; Park JH; Park H; Roh EY; Yoon JH; Shin S
    Virol J; 2020 May; 17(1):70. PubMed ID: 32448303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer.
    Amaro-Filho SM; Pereira Chaves CB; Felix SP; Basto DL; de Almeida LM; Moreira MAM
    Papillomavirus Res; 2018 Jun; 5():172-179. PubMed ID: 29649654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogeny and Classification of Human Papillomavirus (HPV)16 and HPV18 Variants Based on E6 and L1 genes in Tunisian Women with Cervical Lesions.
    Jendoubi-Ferchichi M; Satouri L; Ghoul F; Malek-Mellouli M; Derbel AM; Makni MK; Reziga H; Baba A; Zili M; Segondy M; Khelifa R
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3361-3366. PubMed ID: 30583341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas.
    Liu SS; Tsang PC; Chan KY; Cheung AN; Chan KK; Leung RC; Ngan HY
    Tumour Biol; 2008; 29(2):105-13. PubMed ID: 18515988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Distribution of human papillomavirus genotypes in early-stadge cervical adenocarcinoma and its clinical significance].
    Yang X; Xu J; Cheng X; Xie X; Lü W
    Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(45):3583-5. PubMed ID: 25622839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.